JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Total Liabilities : ¥895 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is JiangXi Tianxin Pharmaceutical Co Total Liabilities?

JiangXi Tianxin Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥895 Mil.

JiangXi Tianxin Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2023 (¥658.44 Mil) to Dec. 2023 (¥857.21 Mil) and increased from Dec. 2023 (¥857.21 Mil) to Mar. 2024 (¥895.05 Mil).

JiangXi Tianxin Pharmaceutical Co's annual Total Liabilities declined from Dec. 2021 (¥1,043.57 Mil) to Dec. 2022 (¥621.98 Mil) but then increased from Dec. 2022 (¥621.98 Mil) to Dec. 2023 (¥857.21 Mil).

JiangXi Tianxin Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for JiangXi Tianxin Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JiangXi Tianxin Pharmaceutical Co Total Liabilities Chart

JiangXi Tianxin Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,350.02

1,760.45

1,043.57

621.98

857.21

JiangXi Tianxin Pharmaceutical Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial											571.64	727.29	658.44	857.21	895.05

JiangXi Tianxin Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

JiangXi Tianxin Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	461.328	+	(5.096	+	390.788
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	857

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	5090.159	-	4232.947
	=	857

JiangXi Tianxin Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	508.888	+	(4.482	+	381.678
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	895

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	5249.611	-	4354.563
	=	895

JiangXi Tianxin Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of JiangXi Tianxin Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300

Website

http://www.txpharm.com

JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Headlines

No Headlines